Grant: Applied Research and Development Grants - Level 1
La Cité collégiale
$24,997.00
Development of a diagnostic tool for rapid detection of group A streptococcus
FY 2016-17
Summary
Spartan Bioscience Inc. aims to develop a rapid diagnostic tool to help point of care providers swiftly identifyand treat infectious diseases before they become rampant. One of these often misdiagnosed diseases is group Astreptococcus, more specifically Streptococcus pyogenes, a leading cause of bacterial sore throats (oftenreferred as strep throat) and skin infections.The main objective of this collaboration is to help Spartan Bioscience Inc. develop a selective and specificsample-to-results diagnostic kit. This technology would help physicians throughout the Canadian healthcaresystem specifically diagnose and start treatment of a strep infection within the hour.The role of the Technology Access Centre in Bio-Innovation will be to support Spartan Bioscience Inc. indetermining the limits of detection of their kit, as well as the specificity to endemic and local strains causingthe disease.The outcome of this partnership will help physicians rapidly diagnose and treat infections, lowering the alreadyincreasing pressures on our healthcare system.
Program
Applied Research and Development Grants - Level 1
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
498638-2016
Name nom
Méthot, Nathalie
Department département
Head Office
Organization id
28248
Institution établissement
La Cité collégiale
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
24997
Program id
CARD1
Program name en
Applied Research and Development Grants - Level 1
Program name fr
Subventions de recherche et développement appliquée - niveau 1
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1561
Committee name en
Applied Research and Development Grants
Committee name fr
Subventions de recherche et développement appliquée
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5300
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Molecular biology
Research subject fr
Biologie moléculaire
Partie
1
Nb partie
1
Application title
Development of a diagnostic tool for rapid detection of group A streptococcus
Keyword
NSERC
Application summary
Spartan Bioscience Inc. aims to develop a rapid diagnostic tool to help point of care providers swiftly identifyand treat infectious diseases before they become rampant. One of these often misdiagnosed diseases is group Astreptococcus, more specifically Streptococcus pyogenes, a leading cause of bacterial sore throats (oftenreferred as strep throat) and skin infections.The main objective of this collaboration is to help Spartan Bioscience Inc. develop a selective and specificsample-to-results diagnostic kit. This technology would help physicians throughout the Canadian healthcaresystem specifically diagnose and start treatment of a strep infection within the hour.The role of the Technology Access Centre in Bio-Innovation will be to support Spartan Bioscience Inc. indetermining the limits of detection of their kit, as well as the specificity to endemic and local strains causingthe disease.The outcome of this partnership will help physicians rapidly diagnose and treat infections, lowering the alreadyincreasing pressures on our healthcare system.
